No photo of David Q.H. Wang

View Scopus Profile

David Q.H. Wang, Ph.D., M.D.

  • 4653 Citations
  • 41 h-Index
1995 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David Q.H. Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Apolipoprotein A5 and Gallstone Formation

Wang, D. Q. H.

National Institutes of Health

7/20/18 → 4/30/22

Project: Research project

    • Gene therapy of alcoholic liver disease

    Wang, D. Q. H.

    National Institutes of Health

    8/20/17 → 7/31/20

    Project: Research project

    • GPR30 and Hepatic Cholesterol Homeostasis

    Wang, D. Q. H.

    National Institutes of Health

    7/25/15 → 6/30/20

    Project: Research project

    • Role of GPR30 in Hepatic Lipid Metabolism

    Wang, D. Q. H.

    National Institutes of Health

    9/15/14 → 8/31/15

    Project: Research project

    • The Role of Dysfunctional CCK-1R in Cholelithogenesis

    Wang, D. Q. H.

    National Institutes of Health

    1/15/08 → 12/31/12

    Project: Research project

    • Publications

    Gastrointestinal defects in gallstone and cholecystectomized patients

    Di Ciaula, A., Molina-Molina, E., Bonfrate, L., Wang, D. Q. H., Dumitrascu, D. L. & Portincasa, P., Mar 2019, In : European Journal of Clinical Investigation. 49, 3, e13066.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease

    Grattagliano, I., Montezinho, L. P., Oliveira, P. J., Frühbeck, G., Gómez-Ambrosi, J., Montecucco, F., Carbone, F., Wieckowski, M. R., Wang, D. Q. H. & Portincasa, P., Feb 2019, In : Biochemical Pharmacology. 160, p. 34-45 12 p.

    Research output: Contribution to journal › Review article

    • 6 Scopus citations

    The physical presence of gallstone modulates ex vivo cholesterol crystallization pathways of human bile

    Portincasa, P., Van Erpecum, K. J., Di Ciaula, A. & Wang, D. Q. H., Feb 1 2019, In : Gastroenterology Report. 7, 1, p. 32-41 10 p.

    Research output: Contribution to journal › Article

    Open Access

    • The Role of Diet in the Pathogenesis of Cholesterol Gallstones

    Di Ciaula, A., Garruti, G., Frühbeck, G., De Angelis, M., de Bari, O., Wang, D. Q. H., Lammert, F. & Portincasa, P., Jan 1 2019, In : Current medicinal chemistry. 26, 19, p. 3620-3638 19 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones

    Wang, H. H., Portincasa, P. & Wang, D. Q. H., Jan 1 2019, In : Current medicinal chemistry. 26, 19, p. 3407-3423 17 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations